Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT023 in Advanced Solid Tumors
NCT07797426Phase 2Not yet recruiting
- Sponsor
- Shanghai Ruotuo Biotechnology
- Start
- Sep 2026
- Primary completion
- Jun 2029
01
Overview
A Phase 2 trial of RT023 in solid tumor, sponsored by Shanghai Ruotuo Biotechnology. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
RT023
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07797426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07797426.